Pancreatic Cancer Research

ResearcherNew York UniversityActive in the last 2 years

Gary Deutsch

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2501-0235; OpenAlex author ID A5038549895, A5075207015. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
14
Papers, trials and grants by year

2022: 2 papers · 2023: none · 2024: 4 papers · 2025: 1 paper

Papers 7

  1. Trends and Outcomes of Neoadjuvant Chemotherapy for Clinical Stage T1 Pancreatic Cancer. Co-author DOI 10.1002/jso.28003↗
  2. Comparison of neoadjuvant chemotherapy plus radiation vs. chemotherapy alone on complete pathologic response in pancreatic adenocarcinoma: an analysis of the n… Co-author DOI 10.1007/s44337-024-00145-0↗
  3. Surgery for Oligometastatic Pancreatic Cancer: Defining Biologic Resectability. Co-author DOI 10.1245/s10434-024-15129-8↗
  4. Minorities Face Delays to Pancreatic Cancer Treatment Regardless of Diagnosis Setting. Last author DOI 10.1245/s10434-024-15352-3↗
  5. ASO Author Reflections: Identifying and Understanding How Vulnerable Populations Are Affected by Delays in Pancreatic Cancer Care. Last author DOI 10.1245/s10434-024-15476-6↗
  6. Advance care planning in patients undergoing surgery to resect pancreatic adenocarcinoma: Underlying tension between balancing hope and realism. Co-author DOI 10.1016/j.surg.2021.08.033↗
  7. Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy. Co-author DOI 10.1097/sla.0000000000005558↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Matthew John Weiss · 6 shared papers, 2022–2025 · strength 1.27
  2. Lyudmyla Demyan · 6 shared papers, 2022–2024 · strength 1.16
  3. Danielle K. DePeralta · 6 shared papers, 2022–2025 · strength 1.11
  4. Oliver J. Standring · 5 shared papers, 2022–2025 · strength 0.96
  5. Joseph M. Herman · 5 shared papers, 2022–2024 · strength 0.85
  6. Shruti Koti · 2 shared papers, 2024–2025 · strength 0.57
  7. Shamsher Ali Pasha · 3 shared papers, 2022–2024 · strength 0.49
  8. Daniel A. King · 3 shared papers, 2022–2024 · strength 0.49
  9. Neha L. Lad · 2 shared papers, 2024–2025 · strength 0.46
  10. Neda Amini · 2 shared papers, 2024–2025 · strength 0.46
  11. John Fallon · 2 shared papers, 2024 · strength 0.38
  12. Matthew John Weiss · 1 shared paper, 2022 · strength 0.15
  13. Grace Wu · 1 shared paper, 2022 · strength 0.15
  14. David Arthur Tuveson · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.